Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region

References

• Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Medical Virol. 2020;92:401–402.
   Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
   Google Scholar
• World Health Organization. Coronavirus disease (COVID-19) outbreak. [ Updated 2020 July 23; cited 2020 Step 12]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline
   Google Scholar
• Rodriguez-Horales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Latin American network of Coronavirus Disease 2019-Covid-19 (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. [in press].
   Google Scholar
• Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis and treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782–793.
   Google Scholar
• Liang W-H, Guan W-J, Li -C-C, et al. Clinical characteristics and outcomes of hospitalized patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): a nationwide analysis of China. Eur Resp J. 2020;55:2000562. [in press].
   Google Scholar
• Royal College of Physicians. National Early Warning Score (NEWS)2. Standardizing the assessment of acute-illness severity in the NHS. Updated 2017 Dec.
   Google Scholar
• National Health Commission and State Administration of Tradition Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (version 7). Chinese Med J. 2020;133:1087–1095.
   Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical medical treatment expert group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
   Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Davidson KW and the Northwell COVID-19 research consortium. Presenting characteristics, comorbidities and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059.
   Google Scholar
• Docherty AB, Morrison EM, Green CA, et al. Features of 20133 UK patients’ hospital with Covid-19 using the ISARIC WHO clinical characterization protocol: prospective observational cohort study. BMJ. 2020;309:m1985. [in press].
   Google Scholar
• Nachtigall I, Lenga P, Jóźwiak K, et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. Clin Microbiol Infect. 2020;26: 1663–1669.
   Google Scholar
• Karagiannidis C, Mostert C, Hentschker C, et al. Characteristics, resource use and outcomes of 10021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Resp Med. 2020;8:853–862.
   Google Scholar
• Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of Hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;383:517–525.
   Google Scholar
• Furtado RHM, Berwanger O, Fonseca HA, et al. COALITION COVID-19 Brazil II Investigators. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomized clinical trial. Lancet 2020;S0140-6736(20)31862–6. [in press]. DOI:10.1016/S0140-6736(20)31862-6.
   Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomized double-blind, placebo-controlled, multicenter trial. Lancet. 2020 16;393:1569–1578.
   Google Scholar
• Deftereos SG, Giannopoulos G, Vrachatis D, et al. Effect of colchicine versus standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with Coronavirus Disease 2019. The CRECCO-19 randomized Clinical Trial. JAMA Network Open. 2020;5:e2013136. [in press].
   Google Scholar
• Horby P, Lim WS, Embeson JR, et al. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2020;NEJMoa2021436. [in press].
   Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis and angiogenesis in Covid-19. N Engl J Med. 2020;383:120–128.
   Google Scholar
• Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and mortality associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Network Open. 2020;3:e2012270. [in press].
   Google Scholar
• Iaccarino G, Grassi G, Borghi C, et al.; Volpe, on behalf of the SARS-RAS Investigators. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension. 2020;76:366–372.
   Google Scholar
• Zhao Z, Chen A, Hou W, et al. Prediction model and risk scores of ICU admission and mortality in COVID-19. PLoS One. 2020;15:e0236618. [in press].
   Google Scholar
• Dong Y-M, Sun J, Li Y-X, et al. Development and validation of a nomogram for assessing survival in patients with COVID-19 pneumonia. Clin Inf Dis.  2021;72:652-660.. [in press].
   Google Scholar